Search
Free Newsletters
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
Editions
Español
Deutsch
Français
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
About
Editions
Español
Deutsch
Français
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
TSLA
-6.23%
$218.75
-$14.54
AAPL
-6.20%
$170.21
-$11.25
NVDA
-2.79%
$94.92
-$2.72
CMCSA
-2.70%
$32.57
-$0.91
META
-2.15%
$505.13
-$11.12
JPM
-0.22%
$213.96
-$0.48
MSFT
-1.77%
$351.52
-$6.34
AMZN
-3.23%
$169.60
-$5.66
GOOGL
-2.20%
$143.52
-$3.23
FOXA
-2.77%
$47.21
-$1.35
TSLA
-6.23%
$218.75
-$14.54
AAPL
-6.20%
$170.21
-$11.25
NVDA
-2.79%
$94.92
-$2.72
CMCSA
-2.70%
$32.57
-$0.91
META
-2.15%
$505.13
-$11.12
JPM
-0.22%
$213.96
-$0.48
MSFT
-1.77%
$351.52
-$6.34
AMZN
-3.23%
$169.60
-$5.66
GOOGL
-2.20%
$143.52
-$3.23
FOXA
-2.77%
$47.21
-$1.35
Markets
RECENT NEWS
Hims & Hers stock slipped as investors were left unimpressed with its new weight-loss drug options
April 2, 2025
Novo Holdings' earnings nearly doubled in 2024, despite Novo Nordisk's stock slump
April 2, 2025
Here's how much Ozempic and similar drugs have soared in popularity since 2018
April 1, 2025
🌏 Target’s Costco strategy
April 1, 2025
Advertisement